260 related articles for article (PubMed ID: 36325577)
41. Eukaryotic translation initiation factors as promising targets in cancer therapy.
Hao P; Yu J; Ward R; Liu Y; Hao Q; An S; Xu T
Cell Commun Signal; 2020 Nov; 18(1):175. PubMed ID: 33148274
[TBL] [Abstract][Full Text] [Related]
42. Targeting PI3K/AKT/mTOR Signaling Pathway in Pancreatic Cancer: From Molecular to Clinical Aspects.
Stanciu S; Ionita-Radu F; Stefani C; Miricescu D; Stanescu-Spinu II; Greabu M; Ripszky Totan A; Jinga M
Int J Mol Sci; 2022 Sep; 23(17):. PubMed ID: 36077529
[TBL] [Abstract][Full Text] [Related]
43. Translation Regulation by eIF2α Phosphorylation and mTORC1 Signaling Pathways in Non-Communicable Diseases (NCDs).
Rios-Fuller TJ; Mahe M; Walters B; Abbadi D; Pérez-Baos S; Gadi A; Andrews JJ; Katsara O; Vincent CT; Schneider RJ
Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32722591
[TBL] [Abstract][Full Text] [Related]
44. ERK and AKT signaling cooperate to translationally regulate survivin expression for metastatic progression of colorectal cancer.
Ye Q; Cai W; Zheng Y; Evers BM; She QB
Oncogene; 2014 Apr; 33(14):1828-39. PubMed ID: 23624914
[TBL] [Abstract][Full Text] [Related]
45. Synergistic inhibition of ovarian cancer cell growth by combining selective PI3K/mTOR and RAS/ERK pathway inhibitors.
Sheppard KE; Cullinane C; Hannan KM; Wall M; Chan J; Barber F; Foo J; Cameron D; Neilsen A; Ng P; Ellul J; Kleinschmidt M; Kinross KM; Bowtell DD; Christensen JG; Hicks RJ; Johnstone RW; McArthur GA; Hannan RD; Phillips WA; Pearson RB
Eur J Cancer; 2013 Dec; 49(18):3936-44. PubMed ID: 24011934
[TBL] [Abstract][Full Text] [Related]
46. Translational control by oncogenic signaling pathways.
Gao B; Roux PP
Biochim Biophys Acta; 2015 Jul; 1849(7):753-65. PubMed ID: 25477072
[TBL] [Abstract][Full Text] [Related]
47. Targeting the translational apparatus to improve leukemia therapy: roles of the PI3K/PTEN/Akt/mTOR pathway.
Martelli AM; Evangelisti C; Chappell W; Abrams SL; Bäsecke J; Stivala F; Donia M; Fagone P; Nicoletti F; Libra M; Ruvolo V; Ruvolo P; Kempf CR; Steelman LS; McCubrey JA
Leukemia; 2011 Jul; 25(7):1064-79. PubMed ID: 21436840
[TBL] [Abstract][Full Text] [Related]
48. Gemcitabine resistance in breast cancer cells regulated by PI3K/AKT-mediated cellular proliferation exerts negative feedback via the MEK/MAPK and mTOR pathways.
Yang XL; Lin FJ; Guo YJ; Shao ZM; Ou ZL
Onco Targets Ther; 2014; 7():1033-42. PubMed ID: 24966685
[TBL] [Abstract][Full Text] [Related]
49. Adaptive Protein Translation by the Integrated Stress Response Maintains the Proliferative and Migratory Capacity of Lung Adenocarcinoma Cells.
Albert AE; Adua SJ; Cai WL; Arnal-Estapé A; Cline GW; Liu Z; Zhao M; Cao PD; Mariappan M; Nguyen DX
Mol Cancer Res; 2019 Dec; 17(12):2343-2355. PubMed ID: 31551255
[TBL] [Abstract][Full Text] [Related]
50. Chronic oxycodone induces integrated stress response in rat brain.
Fan R; Schrott LM; Snelling S; Ndi J; Arnold T; Korneeva NL
BMC Neurosci; 2015 Sep; 16():58. PubMed ID: 26377394
[TBL] [Abstract][Full Text] [Related]
51. Y-box binding protein 1: providing a new angle on translational regulation.
Evdokimova V; Ovchinnikov LP; Sorensen PH
Cell Cycle; 2006 Jun; 5(11):1143-7. PubMed ID: 16721060
[TBL] [Abstract][Full Text] [Related]
52. Reovirus and the Host Integrated Stress Response: On the Frontlines of the Battle to Survive.
Bussiere LD; Miller CL
Viruses; 2021 Jan; 13(2):. PubMed ID: 33525628
[TBL] [Abstract][Full Text] [Related]
53. Targeted profiling of RNA translation reveals mTOR-4EBP1/2-independent translation regulation of mRNAs encoding ribosomal proteins.
Li BB; Qian C; Gameiro PA; Liu CC; Jiang T; Roberts TM; Struhl K; Zhao JJ
Proc Natl Acad Sci U S A; 2018 Oct; 115(40):E9325-E9332. PubMed ID: 30224479
[TBL] [Abstract][Full Text] [Related]
54. Phosphorylation of eIF4E by MNKs supports protein synthesis, cell cycle progression and proliferation in prostate cancer cells.
Bianchini A; Loiarro M; Bielli P; Busà R; Paronetto MP; Loreni F; Geremia R; Sette C
Carcinogenesis; 2008 Dec; 29(12):2279-88. PubMed ID: 18809972
[TBL] [Abstract][Full Text] [Related]
55. N
Zhou J; Wan J; Shu XE; Mao Y; Liu XM; Yuan X; Zhang X; Hess ME; Brüning JC; Qian SB
Mol Cell; 2018 Feb; 69(4):636-647.e7. PubMed ID: 29429926
[TBL] [Abstract][Full Text] [Related]
56. [Future targeting of the RAS/RAF/MEK/ERK signaling pathway in oncology: the example of melanoma].
Favre G
Bull Acad Natl Med; 2014 Feb; 198(2):321-36; discussion 337-8. PubMed ID: 26263707
[TBL] [Abstract][Full Text] [Related]
57. Acquisition of anoikis resistance promotes alterations in the Ras/ERK and PI3K/Akt signaling pathways and matrix remodeling in endothelial cells.
de Sousa Mesquita AP; de Araújo Lopes S; Pernambuco Filho PCA; Nader HB; Lopes CC
Apoptosis; 2017 Sep; 22(9):1116-1137. PubMed ID: 28653224
[TBL] [Abstract][Full Text] [Related]
58. Monitoring flux in signalling pathways through measurements of 4EBP1-mediated eIF4F complex assembly.
Frosi Y; Usher R; Lian DTG; Lane DP; Brown CJ
BMC Biol; 2019 May; 17(1):40. PubMed ID: 31118010
[TBL] [Abstract][Full Text] [Related]
59. Peculiarities of the regulation of translation initiation in plants.
Castellano MM; Merchante C
Curr Opin Plant Biol; 2021 Oct; 63():102073. PubMed ID: 34186463
[TBL] [Abstract][Full Text] [Related]
60. FOXD1-AS1 regulates FOXD1 translation and promotes gastric cancer progression and chemoresistance by activating the PI3K/AKT/mTOR pathway.
Wu Q; Ma J; Wei J; Meng W; Wang Y; Shi M
Mol Oncol; 2021 Jan; 15(1):299-316. PubMed ID: 32460412
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
